UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy

European journal of clinical microbiology & infectious diseases, 2009-03, Vol.28 (3), p.297-300

2009

Volltextzugriff (PDF)

IUGR Management: New Perspectives

Journal of Pregnancy, 2014-01, Vol.2014 (2014), p.129-136

2014

Volltextzugriff (PDF)

Can we treat ulcerative colitis with nutritional supplements?

Alimentary pharmacology & therapeutics, 2012-02, Vol.35 (4), p.485-486

2012

Volltextzugriff (PDF)

CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDREN: Case Reports of Spontaneous Recovery Without Splenectomy

Pediatric hematology and oncology, 2006-09, Vol.23 (6), p.471-475

2006

Volltextzugriff (PDF)

P139 A potential protective rule of Mannose Binding lectin (MBL) against SARS-COV2 infection in IBD patients

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i436-i436

2024

Volltextzugriff (PDF)

DOP36 Vedolizumab-treated IBD patients show an increased gut microbial diversity associated with a specific serum metabolic signature

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i99-i101

2023

Volltextzugriff (PDF)

Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy

European journal of clinical microbiology & infectious diseases, 2009-07, Vol.28 (7), p.879-879

2009

Volltextzugriff (PDF)

DOP21 Potential mechanisms linking biological therapies on SARS-CoV-2 susceptibility in Inflammatory Bowel Disease patients

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i070-i071

2022

Volltextzugriff (PDF)

P771 Biologics versus azathioprine in steroid-dependent ulcerative colitis: results from the A.U.R.O.R.A. database

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i900-i900

2023

Volltextzugriff (PDF)

Maintenance of remission with infliximab in inflammatory bowel disease: efficacy and safety long-term follow-up

World journal of gastroenterology : WJG, 2007-10, Vol.13 (39), p.5238

2007

Volltextzugriff (PDF)

Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression

Nature communications, 2018-11, Vol.9 (1), p.5099-13, Article 5099

2018

Volltextzugriff (PDF)

Teledermatology for acne during COVID‐19: high patients’ satisfaction in spite of the emergency

Journal of the European Academy of Dermatology and Venereology, 2020-11, Vol.34 (11), p.e662-e663

2020

Volltextzugriff (PDF)

Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline

Practical Radiation Oncology, 2020-07, Vol.10 (4), p.220-234

2020

Volltextzugriff (PDF)

Maskne prevalence and risk factors during the COVID‐19 pandemic

Journal of the European Academy of Dermatology and Venereology, 2022-09, Vol.36 (9), p.e678-e680

2022

Volltextzugriff (PDF)

Characterization of ovarian cancer cell lines as in vivo models for preclinical studies

Gynecologic oncology, 2016-08, Vol.142 (2), p.332-340

2016

Volltextzugriff (PDF)

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial

JAMA oncology, 2019-03, Vol.5 (3), p.393

2019

Volltextzugriff (PDF)

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience

Clinical, cosmetic and investigational dermatology, 2023-01, Vol.16, p.135-148

2023

Volltextzugriff (PDF)

Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity

Journal of clinical oncology, 2008-08, Vol.26 (22), p.3709-3714

2008

Volltextzugriff (PDF)

Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions

British journal of cancer, 2013-08, Vol.109 (4), p.1072-1078

2013

Volltextzugriff (PDF)

Overcoming the challenges of drug development in platinum-resistant ovarian cancer

Frontiers in oncology, 2023-10, Vol.13, p.1258228-1258228

2023

Volltextzugriff (PDF)

Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses

JNCI : Journal of the National Cancer Institute, 2014-06, Vol.106 (6), p.dju089

2014

Volltextzugriff (PDF)

A phase II study of durvalumab, a PD-L1 inhibitor and olaparib in recurrent ovarian cancer (OvCa)

Annals of oncology, 2018-10, Vol.29, p.viii334-viii334

2018

Volltextzugriff (PDF)

Short-term associations between fine and coarse particulate matter and hospitalizations in Southern Europe: results from the MED-PARTICLES project

Environmental health perspectives, 2013-09, Vol.121 (9), p.1026-1033

2013

Volltextzugriff (PDF)

Integrated exome and transcriptome analysis prioritizes MAP4K4 de novo frameshift variants in autism spectrum disorder as a novel disease–gene association

Human genetics, 2023-03, Vol.142 (3), p.343-350

2023

Volltextzugriff (PDF)

The role of bone anabolic drugs in the management of periodontitis: a scoping review

European Cells and Materials, 2021-03, Vol.41, p.316-331

2021

Volltextzugriff (PDF)

1 – 25 von 503

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(414)
Mit Volltextzugriff
(400)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(316)
Life Sciences & Biomedicine
(255)
Humans
(222)
Female
(141)
Adult
(107)
Biological And Medical Sciences
(106)
Male
(96)
Medical Sciences
(95)
Middle Aged
(79)
Aged
(51)
Physical Sciences
(51)
Chemistry
(47)
Oncology
(44)
Hematology
(40)
Adolescent
(33)
Exact Sciences And Technology
(33)
Technology
(30)
Organic Chemistry
(29)
Hematologic And Hematopoietic Diseases
(28)
Young Adult
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy

IUGR Management: New Perspectives

Can we treat ulcerative colitis with nutritional supplements?

CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDREN: Case Reports of Spontaneous Recovery Without Splenectomy

P139 A potential protective rule of Mannose Binding lectin (MBL) against SARS-COV2 infection in IBD patients

DOP36 Vedolizumab-treated IBD patients show an increased gut microbial diversity associated with a specific serum metabolic signature

Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy

DOP21 Potential mechanisms linking biological therapies on SARS-CoV-2 susceptibility in Inflammatory Bowel Disease patients

P771 Biologics versus azathioprine in steroid-dependent ulcerative colitis: results from the A.U.R.O.R.A. database

Maintenance of remission with infliximab in inflammatory bowel disease: efficacy and safety long-term follow-up

Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression

Teledermatology for acne during COVID‐19: high patients’ satisfaction in spite of the emergency

Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline

Maskne prevalence and risk factors during the COVID‐19 pandemic

Characterization of ovarian cancer cell lines as in vivo models for preclinical studies

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience

Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity

Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions

Overcoming the challenges of drug development in platinum-resistant ovarian cancer

Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses

A phase II study of durvalumab, a PD-L1 inhibitor and olaparib in recurrent ovarian cancer (OvCa)

Short-term associations between fine and coarse particulate matter and hospitalizations in Southern Europe: results from the MED-PARTICLES project

Integrated exome and transcriptome analysis prioritizes MAP4K4 de novo frameshift variants in autism spectrum disorder as a novel disease–gene association

The role of bone anabolic drugs in the management of periodontitis: a scoping review

Suchergebnisse filtern